J&J Pacific diabetes
March 6, 2013
JOHNSON & Johnson Pacific is set
to broaden its pharmacy
repertoire to include diabetes
management, having assumed
representation for the range of
blood glucose monitors marketed
under the LifeScan OneTouch
brand.
The move is part of a joint
initiative by Johnson & Johnson
Pacific and its affiliate, Johnson &
Johnson Medical, to expand
pharmacy access to LifeScan
products, with the arrangement set
to see J&J Pacific take on
responsibility for sales,
merchandising, account
management and in-store training
for pharmacy customers.
Meanwhile Johnson & Johnson
Medical will maintain marketing,
customer service and distribution
of LifeScan products, whilst
continuing to represent the brand
to healthcare professionals and
diabetes educators.
Speaking about the move
Johnson & Johnson Pacific
Managing Director, Phil Lynch, said
“Diabetes care is increasingly one
of Australia’s most significant
health priorities”.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 13
